The PDGFRβ/ERK1/2 pathway regulates CDCP1 expression in triple-negative breast cancer

BACKGROUND: CDCP1, a transmembrane protein with tumor pro-metastatic activity, was recently identified as a prognostic marker in TNBC, the most aggressive breast cancer subtype still lacking an effective molecular targeted therapy. The mechanisms driving CDCP1 over-expression are not fully understoo...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:BMC Cancer
Main Authors: Forte, Luca, Turdo, Federica, Ghirelli, Cristina, Aiello, Piera, Casalini, Patrizia, Iorio, Marilena Valeria, D’Ippolito, Elvira, Gasparini, Patrizia, Agresti, Roberto, Belmonte, Beatrice, Sozzi, Gabriella, Sfondrini, Lucia, Tagliabue, Elda, Campiglio, Manuela, Bianchi, Francesca
Formato: Artigo
Idioma:Inglês
Publicado: BioMed Central 2018
Assuntos:
Research Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC5967041/
https://ncbi.nlm.nih.gov/pubmed/29792166
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12885-018-4500-9
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares